![]() |
||||||
|
![]() | Fusion Gene Summary |
![]() | Fusion Gene ORF analysis |
![]() | Fusion Genomic Features |
![]() | Fusion Protein Features |
![]() | Fusion Gene Sequence |
![]() | Fusion Gene PPI analysis |
![]() | Related Drugs |
![]() | Related Diseases |
Fusion gene:ARIH2-RHOA (FusionGDB2 ID:HG10425TG387) |
Fusion Gene Summary for ARIH2-RHOA |
![]() |
Fusion gene information | Fusion gene name: ARIH2-RHOA | Fusion gene ID: hg10425tg387 | Hgene | Tgene | Gene symbol | ARIH2 | RHOA | Gene ID | 10425 | 387 |
Gene name | ariadne RBR E3 ubiquitin protein ligase 2 | ras homolog family member A | |
Synonyms | ARI2|TRIAD1 | ARH12|ARHA|EDFAOB|RHO12|RHOH12 | |
Cytomap | ('ARIH2')('RHOA') 3p21.31 | 3p21.31 | |
Type of gene | protein-coding | protein-coding | |
Description | E3 ubiquitin-protein ligase ARIH2RING-type E3 ubiquitin transferase ARIH2all-trans retinoic acid inducible RING fingerariadne homolog 2protein ariadne-2 homolog | transforming protein RhoAAplysia ras-related homolog 12epididymis secretory sperm binding proteinoncogene RHO H12small GTP binding protein RhoA | |
Modification date | 20200313 | 20200329 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000356401, ENST00000449376, ENST00000490095, | ||
Fusion gene scores | * DoF score | 10 X 9 X 7=630 | 25 X 14 X 7=2450 |
# samples | 12 | 31 | |
** MAII score | log2(12/630*10)=-2.39231742277876 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(31/2450*10)=-2.9824416286157 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: ARIH2 [Title/Abstract] AND RHOA [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | ARIH2(48960244)-RHOA(49413024), # samples:4 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ARIH2 | GO:0000209 | protein polyubiquitination | 16118314|19340006 |
Hgene | ARIH2 | GO:0006511 | ubiquitin-dependent protein catabolic process | 16118314 |
Hgene | ARIH2 | GO:0016567 | protein ubiquitination | 24076655 |
Hgene | ARIH2 | GO:0048588 | developmental cell growth | 19340006 |
Hgene | ARIH2 | GO:0070534 | protein K63-linked ubiquitination | 19340006 |
Hgene | ARIH2 | GO:0070936 | protein K48-linked ubiquitination | 16118314|19340006 |
Hgene | ARIH2 | GO:0071425 | hematopoietic stem cell proliferation | 16118314|19340006 |
Tgene | RHOA | GO:0007266 | Rho protein signal transduction | 26529257 |
Tgene | RHOA | GO:0016477 | cell migration | 26529257 |
Tgene | RHOA | GO:0032956 | regulation of actin cytoskeleton organization | 25911094 |
Tgene | RHOA | GO:0035385 | Roundabout signaling pathway | 26529257 |
Tgene | RHOA | GO:0036089 | cleavage furrow formation | 16103226 |
Tgene | RHOA | GO:0051496 | positive regulation of stress fiber assembly | 15467718 |
Tgene | RHOA | GO:0060193 | positive regulation of lipase activity | 19887681 |
Tgene | RHOA | GO:0071222 | cellular response to lipopolysaccharide | 19734146 |
Tgene | RHOA | GO:0071902 | positive regulation of protein serine/threonine kinase activity | 8617235 |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | BLCA | TCGA-FD-A3B8-01A | ARIH2 | chr3 | 48960244 | - | RHOA | chr3 | 49413024 | - |
ChimerDB4 | BLCA | TCGA-FD-A3B8-01A | ARIH2 | chr3 | 48960244 | + | RHOA | chr3 | 49413024 | - |
ChimerDB4 | BLCA | TCGA-FD-A3B8 | ARIH2 | chr3 | 48960244 | + | RHOA | chr3 | 49413024 | - |
Top |
Fusion Gene ORF analysis for ARIH2-RHOA |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5UTR-5UTR | ENST00000356401 | ENST00000418115 | ARIH2 | chr3 | 48960244 | + | RHOA | chr3 | 49413024 | - |
5UTR-5UTR | ENST00000356401 | ENST00000422781 | ARIH2 | chr3 | 48960244 | + | RHOA | chr3 | 49413024 | - |
5UTR-5UTR | ENST00000356401 | ENST00000454011 | ARIH2 | chr3 | 48960244 | + | RHOA | chr3 | 49413024 | - |
5UTR-5UTR | ENST00000449376 | ENST00000418115 | ARIH2 | chr3 | 48960244 | + | RHOA | chr3 | 49413024 | - |
5UTR-5UTR | ENST00000449376 | ENST00000422781 | ARIH2 | chr3 | 48960244 | + | RHOA | chr3 | 49413024 | - |
5UTR-5UTR | ENST00000449376 | ENST00000454011 | ARIH2 | chr3 | 48960244 | + | RHOA | chr3 | 49413024 | - |
5UTR-intron | ENST00000356401 | ENST00000265538 | ARIH2 | chr3 | 48960244 | + | RHOA | chr3 | 49413024 | - |
5UTR-intron | ENST00000449376 | ENST00000265538 | ARIH2 | chr3 | 48960244 | + | RHOA | chr3 | 49413024 | - |
intron-5UTR | ENST00000490095 | ENST00000418115 | ARIH2 | chr3 | 48960244 | + | RHOA | chr3 | 49413024 | - |
intron-5UTR | ENST00000490095 | ENST00000422781 | ARIH2 | chr3 | 48960244 | + | RHOA | chr3 | 49413024 | - |
intron-5UTR | ENST00000490095 | ENST00000454011 | ARIH2 | chr3 | 48960244 | + | RHOA | chr3 | 49413024 | - |
intron-intron | ENST00000490095 | ENST00000265538 | ARIH2 | chr3 | 48960244 | + | RHOA | chr3 | 49413024 | - |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for ARIH2-RHOA |
![]() |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Top |
Fusion Protein Features for ARIH2-RHOA |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:48960244/:49413024) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for ARIH2-RHOA |
![]() |
Top |
Fusion Gene PPI Analysis for ARIH2-RHOA |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for ARIH2-RHOA |
![]() (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for ARIH2-RHOA |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | C0024623 | Malignant neoplasm of stomach | 3 | CTD_human | |
Tgene | C0038356 | Stomach Neoplasms | 3 | CTD_human | |
Tgene | C1708349 | Hereditary Diffuse Gastric Cancer | 3 | CTD_human | |
Tgene | C0020981 | Angioimmunoblastic Lymphadenopathy | 2 | CTD_human | |
Tgene | C0079774 | Peripheral T-Cell Lymphoma | 2 | CTD_human | |
Tgene | C0000771 | Abnormalities, Drug-Induced | 1 | CTD_human | |
Tgene | C0002170 | Alopecia | 1 | CTD_human | |
Tgene | C0005684 | Malignant neoplasm of urinary bladder | 1 | CTD_human | |
Tgene | C0005695 | Bladder Neoplasm | 1 | CTD_human | |
Tgene | C0007097 | Carcinoma | 1 | CTD_human | |
Tgene | C0009171 | Cocaine Abuse | 1 | CTD_human | |
Tgene | C0013575 | Ectodermal Dysplasia | 1 | CTD_human | |
Tgene | C0027626 | Neoplasm Invasiveness | 1 | CTD_human | |
Tgene | C0033687 | Proteinuria | 1 | CTD_human | |
Tgene | C0038587 | Substance Withdrawal Syndrome | 1 | CTD_human | |
Tgene | C0040435 | Tooth Diseases | 1 | CTD_human | |
Tgene | C0079772 | T-Cell Lymphoma | 1 | CTD_human | |
Tgene | C0079773 | Lymphoma, T-Cell, Cutaneous | 1 | CTD_human | |
Tgene | C0086189 | Drug Withdrawal Symptoms | 1 | CTD_human | |
Tgene | C0086873 | Pseudopelade | 1 | CTD_human | |
Tgene | C0087169 | Withdrawal Symptoms | 1 | CTD_human | |
Tgene | C0162311 | Androgenetic Alopecia | 1 | CTD_human | |
Tgene | C0162361 | Hidrotic Ectodermal Dysplasia | 1 | CTD_human | |
Tgene | C0162835 | Hypopigmentation disorder | 1 | CTD_human | |
Tgene | C0205696 | Anaplastic carcinoma | 1 | CTD_human | |
Tgene | C0205697 | Carcinoma, Spindle-Cell | 1 | CTD_human | |
Tgene | C0205698 | Undifferentiated carcinoma | 1 | CTD_human | |
Tgene | C0205699 | Carcinomatosis | 1 | CTD_human | |
Tgene | C0235833 | Congenital diaphragmatic hernia | 1 | CTD_human | |
Tgene | C0236736 | Cocaine-Related Disorders | 1 | CTD_human | |
Tgene | C0263477 | Female pattern alopecia (disorder) | 1 | CTD_human | |
Tgene | C0265316 | Neurocutaneous Syndromes | 1 | CTD_human | |
Tgene | C0265699 | Congenital hernia of foramen of Morgagni | 1 | CTD_human | |
Tgene | C0265700 | Congenital hernia of foramen of Bochdalek | 1 | CTD_human | |
Tgene | C0270612 | Leukoencephalopathy | 1 | CTD_human | |
Tgene | C0282160 | Aplasia Cutis Congenita | 1 | CTD_human | |
Tgene | C0376407 | Granulomatous Slack Skin | 1 | CTD_human | |
Tgene | C0376634 | Craniofacial Abnormalities | 1 | CTD_human | |
Tgene | C0600427 | Cocaine Dependence | 1 | CTD_human | |
Tgene | C1706004 | Anhydrotic Ectodermal Dysplasias | 1 | CTD_human | |
Tgene | C1744559 | Congenital ectodermal dysplasia of face | 1 | CTD_human | |
Tgene | C1858991 | Childhood Ataxia with Central Nervous System Hypomyelinization | 1 | CTD_human | |
Tgene | C4083212 | Alopecia, Male Pattern | 1 | CTD_human |